DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Nitz U.
Prospective WSG Phase III PlanB trial: Clinical outcome at 5-year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2- high risk node-negative and -positive breast cancer. Vortrag ESMO/ECCO-Jahrestagung 2016, LBA 8.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.